Mark Vachon, Director at bluebird bio, Inc. (BLUE), sold 8,421 shares at $210.57 ($1.8M) on 2017-12-11, disclosed to the SEC on 2017-12-13.
Open-market sale of $1.8M BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.57 | 300 | $63K | 3.5% |
| 2 | $212.31 | 1,421 | $302K | 16.6% |
| 3 | $212.32 | 1,421 | $302K | 16.6% |
| 4 | $212.65 | 300 | $64K | 3.5% |
| 5 | $217.09 | 800 | $174K | 9.6% |
| 6 | $218.06 | 2,200 |
| $480K |
| 26.4% |
| 7 | $219.50 | 1,979 | $434K | 23.9% |
| Total | $215.91 avg | 8,421 | $1.8M | 100% |
| Filing → |
| BLUE | SELL | 2018-03-19 | $1.4M | — | Filing → |
| BLUE | SELL | 2017-09-14 | $921K | — | Filing → |